Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Oct 27, 2014 schleifer leonard s Officer Automatic Sell 138,426 402.69
Oct 28, 2014 schleifer leonard s Officer Automatic Sell 69,112 400.52 - 410.00
Oct 24, 2014 brown michael s Director Automatic Sell 5,000 399.00
Oct 24, 2014 goldberg murray a Officer Automatic Sell 26,788 395.96 - 404.18
Oct 23, 2014 goldberg murray a Officer Automatic Sell 33,212 391.93
Aug 18, 2014 mccorkle douglas s Officer Automatic Sell 5,875 353.00
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 26, 2014 tessier-lavigne marc Director Disposition (Non Open Market) 200 351.62
Aug 26, 2014 vagelos p roy Officer Disposition (Non Open Market) 161,597 351.62
Aug 27, 2014 yancopoulos george Officer Disposition (Non Open Market) 5,426 351.33
Aug 18, 2014 aberman michael s Officer Automatic Sell 5,139 351.06
Sep 8, 2014 vagelos p roy Officer Automatic Sell 2 351.00
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Sep 10, 2014 vagelos p roy Officer Automatic Sell 10,326 350.07
Aug 19, 2014 aberman michael s Officer Automatic Sell 3,611 350.00
Aug 15, 2014 brown michael s Director Automatic Sell 3,000 349.20
Sep 16, 2014 sanofi Beneficial Owner (10% or more) Buy 31,717 347.78 - 349.91
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Sep 12, 2014 sanofi Beneficial Owner (10% or more) Buy 59,808 345.07 - 347.92
Feb 24, 2014 goldberg murray a Officer Automatic Sell 18,356 342.63
Showing 1-20 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)